(Q33483633)

27 July 2017

title

Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors (English)

1 reference

27 July 2017

Pia Boström

1

1 reference

27 July 2017

Mirva Söderström

2

1 reference

27 July 2017

Tuire Palokangas

3

1 reference

27 July 2017

Tero Vahlberg

4

1 reference

27 July 2017

Yrjö Collan

5

1 reference

27 July 2017

Olli Carpen

6

1 reference

27 July 2017

Pirkko Hirsimäki

7

1 reference

27 July 2017

language of work or name

1 reference

17 July 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

2

1 reference

27 July 2017

page(s)

140

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-0500-2-140

27 July 2017

exact match

0 references

cites work

High cyclin B1 expression is associated with poor survival in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cell cycle, CDKs and cancer: a changing paradigm

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Clinical and pathologic aspects of basal-like breast cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Triple negative tumours: a critical review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Molecular profiling in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cyclin D1 and breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cyclin E and survival in patients with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716358

Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer

10 December 2018

1 reference

12 December 2020

Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients

1 reference

12 December 2020

The importance of prognostic factors in premenopausal women with breast cancer

1 reference

12 December 2020

Cyclin E expression in breast cancer correlates with negative steroid receptor status, HER2 expression, tumor grade and proliferation

1 reference

12 December 2020

Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining

1 reference

12 December 2020

Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-0500-2-140

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference